Skip to main content

Appleton, AA, Kuniholm, MH, Vasquez, E, Cohen, MH, Donohue, J, Floris-Moore, M, Friedman, MR, Hanna, DB, Mimiaga, MJ, Moran, CA, Plankey, MW, Teplin, LA, Shitole, SG, Ware, DS, Jones, DL, Wise, J (2023): Life course history of physical and sexual abuse is associated with cardiovascular disease risk among women living with and without HIV. AIDS, 2024, 38(1):739-750; PMID: 38126350; PMC10939824

Clutton GT, Weideman AMK, Mischell MA, Kallon S, Conrad SZ, Shaw FR, Warren JA, Lin L, Kuruc JD, Xu Y, Gay CM, Armistead PM, G Hudgens M, Goonetilleke NP (2024): CD3 downregulation identifies high-avidity human CD8 T cells. Clin Exp Immunol., 2024, 215(3):279-290; PMID: 37950348; PMC10876116

Gay CL, Hanley PJ, Falcinelli SD, Kuruc JD, Pedersen SM, Kirchherr J, Raines SLM, Motta CM, Lazarski C, Chansky P, Tanna J, Shibli A, Datar A, McCann CD, Sili U, Ke R, Eron JJ, Archin N, Goonetilleke N, Bollard CM, Margolis DM (2024): The effects of human immunodeficiency virus type 1 (HIV-1) antigen-expanded specific T-cell therapy and Vorinostat on persistent HIV-1 infection in people with HIV on antiretroviral therapy. J Infect Dis, 2024, 229(3): 743-752; PMID: 38349333; PMC10938201

Jensen CE, Deal AM, Nyrop KA, Logan M, Mangieri NJ, Strayhorn MD, Miller J, Muss HB, Lichtman EI, Rubinstein SM, Tuchman SA. (2024): Geriatric assessment-guided interventions for older adults with multiple myeloma: A feasibility and acceptability study. J Geriatr Oncol, 2024, 15(2):101680; PMID: 38104482; PMC10922464

McCrimmon, T. Collins, LF, Perez-Brumer, A, Bazzi, AR, Shaffer, VA, Kerrigan, D, Alcaide, ML, Philbin, MM (2024): long-acting injectable antiretrovirals for HIV treatment: A multi-site qualitative study of clinic-level barriers to implementation in the United States. AIDS Patient Care STDS, 2024, 38(2):61-69; PMID: 38381949

Oliveira VHF, Willig AL, Horvat Davey C, Buford TW, Menezes P, Cachay E, Crane HM, Burkholder GA, Gripshover BM, Fleming JG, Cleveland JD, Webel AR. (2024): Brief report: Relationship between adiposity and biomarkers of aging and frailty among adults aging with HIV. J Acquir Immune Defic Syndr., 2024, 95(4):377-382; PMID: 38100820; PMC10922782

Pak J, Nyrop KA, Muss HB, Forster MK, Lund JL. (2024): Quantifying chemotherapy delivery in older an dyounger women with early-stage breast cancer using longitudinal cumulative dose. Oncologist, 2024, Feb 8:oyad349. online ahead of print; PMID: 38330406

Ramakrishnan, A, Fujita, AW, Mehta, CC, Wilson, TE, Shoptaw, S, Carrico, A, Adimora, AA, Eaton, EF, Jones, DL, Chandran, A, Sheth, AN. (2024) J Acquir Immune Defic Syndr, 2024, 95(5):424-430. PMID: 38133580; PMC10927302

Ross, RK, Cole, SR, Edwards, JK, Zivich, PN, Westreich, D, Daniels, JL, Price, JT, Stringer, JSA (2024): Leveraging external validation data: The challenges of transporting measurement error parameters. Epidemiology, 2024, 35(2):196-207, PMID: 38079241; PMC10841744

Scheidell, JD, Elliott, LC, Bennett, AS, Mahachi, M, Lapple, D, Nelson, JAE, Hobbs, MM (2024): Evaluation of self-directed specimen collection for chlamydia and gonorrhea testing among people who use drugs. Int J STD AIDS, 2024, 35(3):217-227; PMID: 37970785

Shahid, A, MacLennan, S, Jones, BR, Sudderuddin, H, Dang, Z, Cobarrubias, K. Duncan, MC, Kinloch, NN, Dapp, MJ, Archin, NM, Fischl, MA, Ofotokun, I, Adimora, A, Gange, S., Aouizerat, B, Kuniholm, MH, Kassaye, S. Mullins, JI, Goldstein, H, Joy, JB, Anastos, K, Brumme, ZL, MACS/WIHS combined cohort study (MWCSS) (2024): The replication-competent HIV reservoir is a genetically restricted, younger subset of the overall pool of HIV proviruses persisting during therapy, which is highly genetically stable. J Virol, 2024, 98(2):e0165523, PMID: 38214547, PMC10878278

Shook-Sa, BE, Zivich, PN, Rosin, SP, Edwards, JK, Adimora, AA, Hudgens, MG, Cole, SR (2024): Fusing trial data for treatment comparisons: Single vs multi-span bridging. Stat Med, 2024, 43(4):793-815; PMID:38110289, PMC10843571

Tierney, HR, Ma, Y, Bacchetti, P, Adimora, AA, Chandran, A, Kempf, M-C, Collins, LF, DeHovitz, J, DiClemente, RJ, French, AL, Jones, DL, Sharma, A, Spence, AB, Hahn, JA, Price, JC, Tien, PC. (2024): Pivoting from in-person to phone survey assessment of alcohol and substance use: Effects on representativeness in a United States prospective cohort of women living with and without HIV. Am J Drug Alcohol Abuse, 2024, 50(1):54-63; PMID: 37956200; PMC10939835

Zivich, PN, Edwards, JK, Lofgren, ET, Cole, SR, Shook-Sa, BE, Lessler, J (2024): Transportability without positivity. Epidemiology, 2024, 35(1):23-31; PMID:37757864; PMC10841168

Banerjee, T, Frongillo, EA, Turan, JM, Sheira, LA, Adedimeji, A, Wilson, T, Merenstein, D, Cohen, M, Adimora, AA, Ofotokun, I, Metsch, L, D’Souza, G, Fischl, MA, Fisher, MC, Tien, PC, Weiser, SD. (2023). Association of higher intake of plant-based foods and protein with slower kidney function decline in women with HIV. J Acquir Immune Defic Syndr, 94(3):203-210; PMID: 37850979; PMC10593493

Barton K, Ferguson JM, Deveson IW, Falcinelli SD, James KS, Kirchherr J, Ramirez C, Gay CL, Hammond JM, Bevear B, Carswell SL, Margolis DM, Smith MA, Adimora AA, Archin NM. (2023): HIVepsilon-seq-scalable characterization of intact persistent proviral HIV reservoirs in women. J Virol, 2023, 97(11):e0070523; PMID: 37843370; PMC10688329

Barton, K, Ferguson, JM, Deveson, IW, Falcinelli, SD, James, KS, Kirchherr, J, Ramirez, C, Gay, CL, Hammond, JM, Bevear, B, Carswell, SL, Margolis, DM, Smith, MA, Adimora, AA, Archin, NM. (2023): HIVepsilon-seq-scalable characterization of intact persistent proviral HIV reservoirs in women. J Virol, 2023, 97(11):e0070523. doi: 10.1128/jvi.00705-23; PMID: 37843370; PMC10688329

Beam JE, Wagner NJ, Lu KY, Rowe SE, Conlon BP, Inflammasome-mediated glucose limitation induces antibiotic tolerance in Staphylococcus aureus. iScience, (2023), 26(10):107942. PMID:37790275; PMC10543182

Chichetto, NE, Gebru, NM, Plankey, MW, Tindle, HA, Koethe, JR< Hanna, DB, Shoptaw, S, Jones, DL, Lazar, JM, Kizer, JR, Cohen, MH, Haberlen, SA, Adimora, AA, Lahiri, CD, Wise, JS, Freiberg, MS (2023): Syndemic trachectories of heavy drinking, smoking, and depressive symptoms are associated with mortality in women living with HIV in the United States from 1994 to 2017. Drug Alcohol Depend, 2023, Aug 1, 249:110838; PMID: 37352734; PMC10726291

Cole SR, Zivich PN, Edwards JK, Ross RK, Shook-Sa BE, Price JT, Stringer JSA. (2023): Missing outcome data in epidemiologic studies. Am J Epidemiol, 2023, 192(1):6-10; PMID: 36222655; PMC10144620

Cole SR, Zivich PN, Edwards JK, Shook-Sa BE, Hudgens MG (2023): Sensitivity analyses for means or proportions with missing outcome data. Epidemiology, 2023, 34(5):645-651; PMID:37155639; PMC10524136

Collins, LF, Palella, FJ Jr, Mehta, CC, Holloway, J, Stosor, V, Lake, JE, Brown, TT, Topper, EF, Naggie, S, Anastos, K, Taylor, TN, Kassaye, S, French, AL, Adimora, AA, Fischl, MA, Kempf, MC, Koletar, SL, Tien, PC, Ofotokun, I, Sheth, N (2023): Aging-related comorbidity burden among women and men with or at-risk for HIV in the US, 2008-2019. JAMA Netw Open, 2023, 6(8):e2327584; PMID: 37548977; PMC10407688

Crockett KB, Schember CO, Bian A, Rebeiro PF, Keruly J, Mayer K, Mathews C, Moore RD, Crane H, Geng E, Napravnik S, Shepherd BE, Mugavero MJ, Turan B, Pettit AC. (2023): Relationships between patient race and residential race context with missed human immunodeficiency virus care visits in the United States, 2010-2015. Clin Infect Dis, 2023, 76(12):2163-2170; PMID: 36757336; PMC10273374

Edwards JK, Cole SR, Shook-Sa BE, Zivich PN, Zhang N, Lesko CR (2023): When does differential outcome misclassification matter for estimating prevalence? Epidemiol, 2023, 34(2):192-200; PMID: 36722801; PMC10237297

Elbur AI, Ghebremichael M, Konkle-Parker D, Jones DL, Collins S, Adimora AA, Schneider MF, Cohen MH, Tamraz B, Plankey M, Wilson T, Adedimeji A, Haberer J, Jacobson DL (2023): Trajectories of antiretroviral therapy adherence and virologic failure in women with HIV in the United States. J Acquir Immune Defic Syndr, 2023, 93(2):162-170; PMID: 36804871; PMC10180014

Elbur, AI, Ghebremichael, M, Konkle-Parker, D, Jones, DL, Collins, S, Adimora, AA, Schneider, MF, Cohen, MH, Tamraz, B, Plankey, M, Wilson, T, Adedimeji, A, Haberer, JE, Jacobson, DL (2023): Dual trajectories of antiviral therapy adherence and polypharmacy in women with HIV in the United States. AIDS Res Ther, 2023, 20(1):29; PMID: 37179294; PMC10182649

Ferrante ND, Kallan MJ, Sukkestad S, Kodani M, Kitahata MM, Cachay ER, Bhattacharya D, Heath S, Napravnik S, Moore RD, Yendewa G, Mayer KH, Reddy KR, Hayden T, Kamili S, Martin JN, Kim HN, Lo Re V 3rd. (2023): Prevalence and determinants of hepatitis delta virus infection among HIV/hepatitis B-coinfected adults in care in the United States. J Viral Hepat., 2023, 30(11):879-888; PMID: 37488783; PMC10592429

Fisher, MC, Hoover, DR, Shi, Q, Sharma, A, Estrella, MM, Adimora, AA, Alcaide, M, Collins, LF, French, A, Gao, W, Koletar, SL, Mcfarlane, SI, Mckay, H, Dionne, JA, Palella, F, Sarkar, S, Spence, A, Witt, MD, Ross, MJ (2023): Association of marijuana, tobacco, and alcohol use with estimated glomerular filtration rate in women living with HIV and women without HIV. AIDS, 2023, 37(10):1555-1564; PMID: 37352493; PMC10859004

Gardner AR, Ma Y, Bacchetti P, Price JC, Kuniholm MH, French AL, Gange S, Adimora AA, Minkoff H, Kassaye S, Ofotokun I, Rosenberg W, Kovacs AAZ, Tien PC (2023): Longitudinal assessment of the enhanced liver fibrosis score in the era of contemporary HIV and hepatitis C treatment. J Infect Dis, 2023, 227(11):1274-1281; PMID: 35951669; PMC10226657

Garimella, PS, Scherzer, R, Kestenbaum, BR, Hoofnagle, AN, Jotwani, V, Gustafson, D, Karim, R, Sharma, A, Cohen, M, Dumond, J, Abraham, A, Estrella, M, Shlipak, MG, Ix, JH (2023): Tubular secretory solute clearance and HIV infection. J Acquir Immune Defic Syndr, 2023, 93(4):319-326; PMID: 36988544; PMC10313730

Graham SM, Nance RM, Chen J, Wurfel MM, Hunt PW, Heckbert SR, Budoff MJ, Moore RD, Jacobson JM, Martin JN, Crane HM, López JA, Liles WC. (2023): plasma interleukin-6 (IL-6), angiopoietin-2, and C-reactive protein levels predict subsequent type 1 myocardial infarction in persons with treated HIV infection. J Acquir Immune Defic Syndr., 2023, 93(4):282-291; PMID: 37018921; PMC10330055

Ingle SM, Miro JM, May MT, Cain LE, Schwimmer C, Zangerle R, Sambatakou H, Cazanave C, Reiss P, Brandes V, Bucher HC, Sabin C, Vidal F, Obel N, Mocroft A, Wittkop L, d’Arminio Monforte A, Torti C, Mussini C, Furrer H, Konopnicki D, Teira R, Saag MS, Crane HM, Moore RD, Jacobson JM, Mathews WC, Geng E, Eron JJ, Althoff KN, Kroch A, Lang R, Gill MJ, Sterne JAC (2023): early antiretroviral thereapy not associated with higher cryptococcal meningitis ortality in people with human immunodeficiency virus in high-income countries: An international collaborative cohort study. Clin Infect Dis, 2023, 77(1)64-73; PMID: 36883578, PMC10320049

Jetsupphasuk, M, Hudgens, MG, Haidong, L, Cole, SR, Edwards, JK, Adimora, AA, Althoff, KN, Silverberg, MJ, Rebeiro, PF, Lima, VD, Marconi, VC, Sterling, TR, Horberg, MA, Gill, MJ, Kitahata, MM, Moore, RD, Lang, R, Gebo, K, Rabkin, C, Eron, JJ (2023): Optimizing treatment for Human immunodeficiency virus to improve clinical outcomes using precision medicine. Am J Epidemiol, 2023, 192(8):1341-1349; PMID: 36922393; PMC10666965

Kim, J, Newcomb, CW, Carbonari, DM, Torgersen, J, Althoff, KN, Kitahata, MM, Klein, MB, Moore, RD, Reddy, KR, Silverberg, MJ, Mayor, AM, Horberg, MA, Cachay, ER, Lim, JK, Gill, MJ, Chew, K, Sterling, KR, Hull, M, Seaberg, EC, Kirk, GD, Coburn, SB, Lang, R, McGinnis, KA, Gebo, KA, Napravnik, S, Kim, HN, Lo, Re V3rd, North American AIDS Cohort Collaboration on Research Design of IeDEA (2023): Hepatitis B care cascade among people with HIV/HBV coinfection in the North American AIDS Cohort Collaboration in Research and Design. PlosOne, 2023, 18(9):e0290889; PMID: 37656704; PMC10473492

Konstantinidis, I, Crothers, K, Kunisaki, KM, Drummond, MB, Benfiled, T, Zar, HJ, Huang, L, Morris, A. (2023): HIV-associated lung disease. Nat Rev Dis Primers, 2024, 9(1):39; PMID: 37500684

Lee WJ, Cheng H, Whitney BM, Nance RM, Britton SR, Jordahl K, Lindstrom S, Ruderman SA, Kitahata MM, Saag MS, Willig AL, Burkholder G, Eron JJ, Kovacic JC, Björkegren JLM, Mathews WC, Cachay E, Feinstein MJ, Budoff M, Hunt PW, Moore RD, Keruly J, McCaul ME, Chander G, Webel A, Mayer KH, Delaney JA, Crane PK, Martinez C, Crane HM, Hao K, Peter I. (2023): polygenic risk scores point toward potential genetic mechanisms of type 2 myocardial infarction in people with HIV. Int J Cardiol., 2023, Jul15; 383-15-23; PMID: 37149004; PMC10247524

Liu, Y, Ramos, SD, Hanna, DB, Jones, DL, Lazar, JM, Kizer, JR, Cohen, MH, Haberlen, SA, Adimora, AA, Lahiri, CD, Wise, JM, Friedman, MR, Plankey, M, Chichetto, NE (2023): Psychsocial Syndemic Clases and longitudinal Transition Patterns among sexual minority men living with or without HIV in the Multicenter AIDS Cohort Study (MACS). AIDS Behav, 2023, 27(12):4094-4105; PMID: 37418062: PMC10615787

Nyrop KA, Monaco J, Vohra S, Deal AM, Wood WA, Shachar SS, Dees EC, Kimmick GG, Speca JC, Muss HB. (2023): Body mass index and patient-reported function, quality of life and treatment toxicity in women receiving adjuvant chemotherapy for breast cancer. Support Care Cancer, 2023, 31(3):196; PMID: 36859693

Nyrop KA, Page A, Deal AM, Wagoner C, Kelly EA, Kimmick GG, Copeland A, Speca J, Wood WA, Muss HB (2023): Association of self-directed walking with toxicity moderation during chemotherapy for the treatment of early breast cancer. Support Care Cancer, 2023, 32(1):68; PMID: 38153568

Palar K, Sheira LA, Frongillo EA, Kushel M, Wilson TE, Conroy AA, Adedimeji A, Merenstein D, Cohen MH, Wentz EL, Adimora AA, Ofotokun I, Metsch LR, Turan JM, Tien PC, Weiser SD. (2023): Longitudinal relationship between food insecurity, engagement in care, and ART adherence among US women living with HIV. AIDS Behav, 2023, 27(10):3345-3355; PMID: 37067613; PMC10783960

Peters BA, Hanna DB, Sharma A, Anastos K, Hoover DR, Shi Q, Moran CA, Jackson EA, Alcaide ML, Ofotokun I, Adimora AA, Haberlen SA, Cohen M, Tien PC, Michel KG, Levine SR, Hodis HN, Kaplan RC, Yin MT (2023): Menopausal hormone therapy and subclinical cardiovascular disease in women with and without human immunodeficiency virus. J. Infect Dis, 2023, 76(3):e661-e670., PMID: 35903868; PMC10169435

Renson A, Hudgens MG, Keil AP, Zivich PN, Aiello AE. (2023): identifying and estimating effects of sustained interventions under parallel trends assumptions. Biometrics, 2023, 79(4):2998-3009; PMID: 36989497; PMC10539489

Sadinski LM, Westreich D, Edmonds A, Breger TL, Cole SR, Ramirez C, Brown TT, Ofotokun I, Konkle-Parker D, Kassaye S, Jones DL, D’Souza G, Cohen MH, Tien PC, Taylor TN, Anastos K, Adimora AA. (2023): Hypertension and one-year risk of all-cause mortality among women with treated HIV in the United States. AIDS, 2023, 37(4):679-688; PMID: 36728933; PMC9974900

Shelton BA, Sawinski D, Peter I, Maclennan PA, Pelletier NF, Nadkarni G, Julian B, Saag M, Fatima H, Crane H, Lee W, Moore RD, Christopoulos K, Jacobson JM, Eron JJ, Kumar V, Locke JE (2023): African American/Black race, apolipoprotein L1, and serum creatinine among persons with HIV. AIDS, 2023, 37(15):2349-2357; PMID: 37650767; PMC10843645

Sponaugle A, Weideman AMK, Ranek J, Atassi G, Kuruc J, Adimora AA, Archin NM, Gay C, Kuritzkes DR, Margolis DM, Vincent BG, Stanley N, Hudgens MG, Eron JJ, Goonetilleke N. (2023): Dominant CD4+ T cell receptors remain stable throughout antiretroviral therapy-mediated immune restoration in people with HIV. Cell Rep Med., 2023, 4(11):101268; PMID: 37949070; PMC10694675

Tang Y, Chaillon A, Gianella S, Wong LM, Li D, Simermeyer TL, Porrachia M, Ignacio C, Woodworth B, Zhong D, Du J, de la Parra Polina E, Kirchherr J, Allard B, Clohosey ML, Moeser M, Sondgeroth AL, Whitehill GD, Singh V, Dashti A, Smith DM, Eron JJ, Bar KJ, Chahroudi A, Joseph SB, Archin NM, Margolis DM, Jiang G. (2023): Brain microglia serve as a persistent reservoir despite durable antiretroviral therapy. J Clin Invest, 2023, 133(12):e167417; PMID: 37317962; PMC10266791

Vasquez, E, Kuniholm, MH, Appleton, AA, Rubin, LH, Adimora, AA, Fischl, MA, Fox, E, Mack, WJ, Holman, S, Moran, CA, Minkoff, H, Plankey, MW, Sharma, A, Tien, PC, Weber, KM, Gustafson, DR (2023): Midlife body mass index, central adiposity and neuropsychological performance over 10 years in women living with and without HIV. Front Endocrinol (Lausanne), 2023, Jul7:141108313; PMID: 37484940; PMC10361616

Waltmann A, Balthazar JT, Begum AA, Hua N, Jerse AE, Shafer WM; UNC-Global Clinical Trials Unit/DMID 09-0106 Study Team; Hobbs MM, Duncan JA (2023): Neisseria gonorrhoeae MtrCDE efflux pump during in vivo experimental genital tract infection in men and mice reveals the presence of within-host colonization bottleneck. medRxiv, 2023 Jun 29:2023.06.23.23291824; PMID: 37425726, PMC10327229

Zalla, LC, Cole, SR, Eron, JJ, Adimora, AA, Vines, AI, Althoff, KN, Marconi, VC, Gill, MJ, Horberg, MA, Silverberg, MJ, Ribeiro, PF, Lang, K, Kasaie, P, Moore, RD, Edwards, JK (2023): Evaluating clinic-based interventions to reduce racial differences in mortality among people with human immunodeficiency virus in the United States. J Infect Dis, 2023, 228(12):1690-1698; PMID: 37437108; PMC10733732

Zhou, S, Long, M, Swanstrom, R. (2023): Evolution driven by a varying host environment selects for distinct HIV-1 entry phenotypes and other informative variants. Front Virol, 2023:3:1291996; PMID: 38239974; PMC10795538

Zivich PN, Cole SR, Edwards JK, Mulholland GE, Shook-Sa BE, Tchetgen Tchetgen EJ. (2023): Introducing proximal casual interference for epidemiologists. Am J Epidemiol, 2023, 192(7):1224-1227; PMID: 37005072; PMC10505426

Abdo M, Wu X, Sharma A, Tassiopoulos KK, Brown TT, Koletar SL, Yin MT and Erlandson KM. Regional Differences in Risk of Recurrent Falls Among Older U.S. Women and Men with HIV in the HIV Infection, Aging, and Immune Function Long-Term Observational Study. AIDS Res Hum Retroviruses. 2022.

Bosch RJ, Gandhi RT, Mar H, Eron JJ, Cyktor JC, McMahon DK, Mellors JW and ACTG A5341s Team. Associations between multiple measures of HIV-1 persistence on suppressive antiretroviral therapy. J Infect Dis. 2022.

Boucau J, Chew KW, Choudhary M, Deo R, Regan J, Flynn JP, Crain CR, Hughes MD, Ritz J, Moser C, Dragavon JA, Javan AC, Nirula A, Klekotka P, Greninger AL, Coombs RW, Fischer WA, Daar ES, Wohl DA, Eron JJ, Currier JS, Smith DM, Li JZ, Barczak AK and ACTIV-2/A5401 Team. Monoclonal antibody treatment drives rapid culture conversion in SARS-CoV-2 infection. medRxiv. 2021. PMC8750705.

Brown LK, Chernoff M, Kennard BD, Emslie GJ, Lypen K, Buisson S, Weinberg A, Whiteley LB, Traite S, Krotje C, Harriff L, Townley E, Bunch A, Purswani M, Shaw R, Spector SA, Agwu A, Shapiro DE and IMPAACT 2002 team. Site-Randomized Controlled Trial of a Combined Cognitive Behavioral Therapy and a Medication Management Algorithm for Treatment of Depression Among Youth Living With HIV in the United States. J Acquir Immune Defic Syndr. 88(5):497-505. 2021. PMC8585710.

Budhwani H, Gakumo CA, Yigit I, Rice WS, Fletcher FE, Whitfield S, Ross S, Konkle-Parker DJ, Cohen MH, Wingood GM, Metsch LR, Adimora AA, Taylor TN, Wilson TE, Weiser SD, Sosanya O, Goparaju L, Gange S, Kempf MC, Turan B and Turan JM. Patient Health Literacy and Communication with Providers Among Women Living with HIV: A Mixed Methods Study. AIDS Behav. 2021.

Budhwani H, Yigit I, Ofotokun I, Konkle-Parker DJ, Cohen MH, Wingood GM, Metsch LR, Adimora AA, Taylor TN, Wilson TE, Weiser SD, Kempf MC, Sosanya O, Gange S, Kassaye S, Turan B and Turan JM. Examining the Relationships Between Experienced and Anticipated Stigma in Health Care Settings, Patient-Provider Race Concordance, and Trust in Providers Among Women Living with HIV. AIDS Patient Care STDS. 35(11):441-448. 2021. PMC8817693.

Caro-Vegas C, Ramirez C, Landis J, Adimora AA, Strickler H, French AL, Ofotokun I, Fischl M, Seaberg EC, Wang CJ, Spence AB and Dittmer DP. Molecular profiling of breast and lung cancer in women with HIV reveals high tumor mutational burden. AIDS. 2021.

Cedarbaum ER, Ma Y, Adimora AA, Bamman M, Cohen MH, Fischl MA, Gustafson D, Matsushita K, Ofotokun I, Plankey M, Seaberg EC, Sharma A and Tien PC. Peripheral artery disease and physical function in women with and without HIV. AIDS. 36(3):347-354. 2022. PMC8795474.

Chen J, Titanji K, Sheth AN, Gandhi R, McMahon D, Ofotokun I, Weitzmann MN, De Paris K and Dumond JB. The effect of age on CD4+ T-cell recovery in HIV-suppressed adult participants: a sub-study from AIDS Clinical Trial Group (ACTG) A5321 and the Bone Loss and Immune Reconstitution (BLIR) study. Immun Ageing. 19(1):4. 2022. PMC8722153.

Chen JS, Matoga M, Massa C, Tegha G, Ndalama B, Bonongwe N, Mathiya E, Jere E, Banda G, Loftis AJ,Lancaster KE, Miller WC, Hoffman IF and Cohen MS. Effects of Urethritis on Human Immunodeficiency Virus (HIV) in Semen: Implications for HIV Prevention and Cure. Clin Infect Dis. 73(7):e2000-e2004. 2021. PMC8492110.

Chen JS, Pettifor AE, Nelson JAE, Phiri S, Pasquale DK, Kumwenda W, Kamanga G, Cottrell ML, Sykes C, Kashuba ADM, Tegha G, Krysiak R, Thengolose I, Cohen MS, Hoffman IF, Miller WC and Rutstein SE. Blood and genital fluid viral load trajectories among treated and untreated persons with acute HIV infection in Malawi. J Acquir Immune Defic Syndr. 2022.

Choudhary MC, Chew KW, Deo R, Flynn JP, Regan J, Crain CR, Moser C, Hughes M, Ritz J, Ribeiro RM, Ke R, Dragavon JA, Javan AC, Nirula A, Klekotka P, Greninger AL, Fletcher CV, Daar ES, Wohl DA, Eron JJ, Currier JS, Parikh UM, Sieg SF, Perelson AS, Coombs RW, Smith DM, Li JZ and ACTIV-2/A5401 Team. Emergence of SARS-CoV-2 Resistance with Monoclonal Antibody Therapy. medRxiv. 2021. PMC8452115.

Conroy AA, Jain JP, Sheira L, Frongillo EA, Neilands TB, Cohen MH, Wilson TE, Chandran A, Adimora AA, Kassaye S, Sheth AN, Fischl MA, Adedimeji A, Turan JM, Tien PC and Weiser SD. Mental Health Mediates the Association Between Gender-Based Violence and HIV Treatment Engagement in US Women. J Acquir Immune Defic Syndr. 89(2):151-158. 2022. PMC8752473.

Crowell TA, Ritz J, Coombs RW, Zheng L, Eron JJ, Mellors JW, Dragavon J, van Zyl GU, Lama JR, Ruxrungtham K, Grinsztejn B, Arduino RC, Fox L, Ananworanich J, Daar ES and ACTG A5354/EARLIER Study Team. Novel Criteria for Diagnosing Acute and Early Human Immunodeficiency Virus Infection in a Multinational Study of Early Antiretroviral Therapy Initiation. Clin Infect Dis. 73(3):e643-e651. 2021. PMC8326583.

D’Souza G, Tong W, Gustafson D, Alcaide ML, Lahiri CD, Sharma A, French AL, Palella FJ, Kempf MC, Mimiaga MJ, Ramirez C, Kassaye S, Rinaldo CR, Brown TT, Tien PC and Adimora AA. SARS-CoV-2 Infection Among People Living With HIV Compared With People Without HIV: Survey Results From the MACS-WIHS Combined Cohort Study. J Acquir Immune Defic Syndr. 89(1):1-8. 2022. PMC8667184.

Daubert E, French AL, Burgess HJ, Sharma A, Gustafson D, Cribbs SK, Weiss DJ, Ramirez C, Konkle-Parker D, Kassaye S and Weber KM. Association of Poor Sleep With Depressive and Anxiety Symptoms by HIV Disease Status: Women’s Interagency HIV Study. J Acquir Immune Defic Syndr. 89(2):222-230. 2022. PMC8740603.

Deese J, Wang M, Lapple D, Nelson JAE, Kuerten B, Steiner MJ, Chen PL and Hobbs MM. What’s Sex Got to Do With It? Understanding Potential Confounding and Exposure Misclassification in Mechanistic Sexually Transmitted Infection Research. J Infect Dis. 224(1):137-140. 2021. PMC8427711.

Diepstra KL, Barr L, Palm D, Hogg E, Mollan KR, Henley L, Stover AM, Simoni JM, Sugarman J, Brown B, Sauceda JA, Deeks S, Fox L, Gandhi RT, Smith D, Li JZ and Dube K. Participant Perspectives and Experiences Entering an Intensively Monitored Antiretroviral Pause: Results from the AIDS Clinical Trials Group A5345 Biomarker Study. AIDS Res Hum Retroviruses. 37(6):489-501. 2021. PMC8213012.

Dunkle LM, Kotloff KL, Gay CL, Anez G, Adelglass JM, Barrat Hernandez AQ, Harper WL, Duncanson DM, McArthur MA, Florescu DF, McClelland RS, Garcia-Fragoso V, Riesenberg RA, Musante DB, Fried DL, Safirstein BE, McKenzie M, Jeanfreau RJ, Kingsley JK, Henderson JA, Lane DC, Ruiz-Palacios GM, Corey L, Neuzil KM, Coombs RW, Greninger AL, Hutter J, Ake JA, Smith K, Woo W, Cho I, Glenn GM, Dubovsky F and 2019nCoV-301 Study Group. Efficacy and Safety of NVX-CoV2373 in Adults in the United States and Mexico. N Engl J Med. 386(6):531-543. 2022. PMC8693692.

Fischer WA, 2nd, Eron JJ, Jr., Holman W, Cohen MS, Fang L, Szewczyk LJ, Sheahan TP, Baric R, Mollan KR, Wolfe CR, Duke ER, Azizad MM, Borroto-Esoda K, Wohl DA, Coombs RW, James Loftis A, Alabanza P, Lipansky F and Painter WP. A phase 2a clinical trial of molnupiravir in patients with COVID-19 shows accelerated SARS-CoV-2 RNA clearance and elimination of infectious virus. Sci Transl Med. 14(628):eabl7430. 2022.

Friedland A, Hernandez AF, Anstrom KJ, Chen-Lim ML, Cohen LW, Currier JS, Forrest CB, Fraser R, Fraulo E, George A, Handberg E, Jackman J, Koellhoffer J, Lawrence D, Leverty R, McAdams P, McCourt B, Mickley B, Naqvi SH, O’Brien EC, Olson R, Prater C, Rothman RL, Shenkman E, Shostak J, Turner KB, Webb L, Woods C, Naggie S and HERO Research Program. Design of the Healthcare Worker Exposure Response and Outcomes (HERO) research platform. Contemp Clin Trials. 109:106525. 2021. PMC8349387.

Friedman MR, Kempf MC, Benning L, Adimora AA, Aouizerat B, Cohen MH, Hatfield Q, Merenstein D, Mimiaga MJ, Plankey MW, Sharma A, Sheth AN, Ramirez C, Stosor V, Wagner MCE, Wilson TE, D’Souza G and Weiss DJ. Prevalence of COVID-19-Related Social Disruptions and Effects on Psychosocial Health in a Mixed-Serostatus Cohort of Men and Women. J Acquir Immune Defic Syndr. 88(5):426-438. 2021. PMC8575096.

Gay CL, Bosch RJ, McKhann A, Moseley KF, Wimbish CL, Hendrickx SM, Messer M, Furlong M, Campbell DM, Jennings C, Benson C, Overton ET, Macatangay BJC, Kuritzkes DR, Miller E, Tressler R, Eron JJ, Hardy WD and A5370 Team. Suspected Immune-Related Adverse Events With an Anti-PD-1 Inhibitor in Otherwise Healthy People With HIV. J Acquir Immune Defic Syndr. 87(5):e234-e236. 2021. PMC8263135.

Gay CL, James KS, Tuyishime M, Falcinelli SD, Joseph SB, Moeser MJ, Allard B, Kirchherr JL, Clohosey M, Raines SLM, Montefiori DC, Shen X, Gorelick RJ, Gama L, McDermott AB, Koup RA, Mascola JR, Floris-Moore M, Kuruc JD, Ferrari G, Eron JJ, Archin NM and Margolis DM. Stable Latent HIV Infection and Low-level Viremia Despite Treatment With the Broadly Neutralizing Antibody VRC07-523LS and the Latency Reversal Agent Vorinostat. J Infect Dis. 225(5):856-861. 2022. PMC8889279.

Gilbert PB, Montefiori DC, McDermott AB, Fong Y, Benkeser D, Deng W, Zhou H, Houchens CR, Martins K, Jayashankar L, Castellino F, Flach B, Lin BC, O’Connell S, McDanal C, Eaton A, Sarzotti-Kelsoe M, Lu Y, Yu C, Borate B, van der Laan LWP, Hejazi NS, Huynh C, Miller J, El Sahly HM, Baden LR, Baron M, De La Cruz L, Gay C, Kalams S, Kelley CF, Andrasik MP, Kublin JG, Corey L, Neuzil KM, Carpp LN, Pajon R, Follmann D, Donis RO, Koup RA, Immune Assays Team, Moderna, Inc. Team, Coronavirus Vaccine Prevention Network (CoVPN)/Coronavirus Efficacy (COVE) Team, and United States Government (USG)/CoVPN Biostatistics Team. Immune correlates analysis of the mRNA-1273 COVID-19 vaccine efficacy clinical trial. Science. 375(6576):43-50. 2022.

Hurt CB, Morrison AS, Guy J, Mobley VL, Dennis AM, Barrington C, Samoff E, Hightow-Weidman LB, McNeil CJ, Carry MG, Hogben M and Sena AC. Beyond Disease Intervention: Exploring an Expanded Role for Partner Services in the MATRix-NC Demonstration Project. Sex Transm Dis. 49(2):93-98. 2022.

Ismail SD, Riou C, Joseph SB, Archin NM, Margolis DM, Perelson AS, Cassidy T, Abrahams MR, Moeser M, Council OD, McKinnon LR, Osman F, Karim QA, Abdool Karim SS, Swanstrom R, Williamson C, Garrett NJ and Burgers WA. Immunological Correlates of the HIV-1 Replication-Competent Reservoir Size. Clin Infect Dis. 73(8):1528-1531. 2021. PMC8528395.

Kelly SG, Wu K, Tassiopoulos K, Erlandson KM, Koletar SL, Palella FJ, Jr. and ACTG A5322 Study Team. Incorporating Frailty Into the Pooled Cohort Equations to Predict Cardiovascular Disease Among Persons With HIV. J Acquir Immune Defic Syndr. 87(3):971-977. 2021. PMC8192418.

Kimani S, Painschab MS, Kaimila B, Kasonkanji E, Zuze T, Tomoka T, Mulenga M, Nyasosela R, Chikasema M, Mtangwanika A, Chawinga M, Mhango W, Nicholas S, Chimzimu F, Kampani C, Krysiak R, Lilly A, Randall C, Seguin R, Westmoreland KD, Montgomery ND, Fedoriw Y and Gopal S. Safety and efficacy of rituximab in patients with diffuse large B-cell lymphoma in Malawi: a prospective, single-arm, non-randomised phase 1/2 clinical trial. Lancet Glob Health. 9(7):e1008-e1016. 2021.

Knittel AK, Rudolph JE, Shook-Sa BE, Edmonds A, Ramirez C, Cohen M, Taylor T, Adedimeji A, Michel KG, Milam J, Cohen J, Donohue JD, Foster A, Fischl MA, Long DM and Adimora AA. Self-Reported Sexually Transmitted Infections After Incarceration in Women with or at Risk for HIV in the United States, 2007-2017. J Womens Health (Larchmt). 2021.

Kreitchmann R, Stek A, Best BM, Capparelli E, Wang J, Shapiro D, Chakhtoura N, Mirochnick M, Eke AC and IMPAACT P1026s protocol team. Interactions between etonogestrel-releasing contraceptive implant and 3 antiretroviral regimens. Contraception. 105:67-74. 2022. PMC8678338.

Krogstad P, Samson P, Acosta EP, Moye J, Townley E, Bradford S, Brown E, Denson K, Graham B, Hovind L, Sise T, Teppler H, Mathiba SR, Fairlie L, Winckler JL, Slade G, Meyers T and IMPAACT P1101 Team. Pharmacokinetics and Safety of a Raltegravir-Containing Regimen in Children Aged 4 Weeks to 2 Years Living With Human Immunodeficiency Virus and Receiving Rifampin for Tuberculosis. J Pediatric Infect Dis Soc. 10(2):201-204. 2021. PMC7996637.

Kuniholm MH, Vasquez E, Appleton AA, Kingsley L, Palella FJ, Budoff M, Michos ED, Fox E, Jones D, Adimora AA, Ofotokun I, D’Souza G, Weber KM, Tien PC, Plankey M, Sharma A and Gustafson DR. Cardiovascular risk score associations with frailty in men and women with or at risk for HIV. AIDS. 36(2):237-347. 2022. PMC8711611.

Landovitz RJ, Donnell D, Clement ME, Hanscom B, Cottle L, Coelho L, Cabello R, Chariyalertsak S, Dunne EF, Frank I, Gallardo-Cartagena JA, Gaur AH, Gonzales P, Tran HV, Hinojosa JC, Kallas EG, Kelley CF, Losso MH, Madruga JV, Middelkoop K, Phanuphak N, Santos B, Sued O, Valencia Huamani J, Overton ET, Swaminathan S, Del Rio C, Gulick RM, Richardson P, Sullivan P, Piwowar-Manning E, Marzinke M, Hendrix C, Li M, Wang Z, Marrazzo J, Daar E, Asmelash A, Brown TT, Anderson P, Eshleman SH, Bryan M, Blanchette C, Lucas J, Psaros C, Safren S, Sugarman J, Scott H, Eron JJ, Fields SD, Sista ND, Gomez-Feliciano K, Jennings A, Kofron RM, Holtz TH, Shin K, Rooney JF, Smith KY, Spreen W, Margolis D, Rinehart A, Adeyeye A, Cohen MS, McCauley M, Grinsztejn B and HPTN 083 Study Team. Cabotegravir for HIV Prevention in Cisgender Men and Transgender Women. N Engl J Med. 385(7):595-608. 2021. PMC8448593.

Li JZ, Aga E, Bosch R, Pilkinton M, Kroon E, MacLaren L, Keefer M, Fox L, Barr L, Acosta E, Anaworanich J, Coombs R, Mellors J, Landay A, Macatangay B, Deeks S, Gandhi RT, Smith DM and ACTG A5345 Study Team. Time to Viral Rebound After Interruption of Modern Antiretroviral Therapies. Clin Infect Dis. 2021.

Liu C, Hufnagel K, O’Connell CM, Goonetilleke N, Mokashi N, Waterboer T, Tollison TS, Peng X, Wiesenfeld HC, Hillier SL, Zheng X and Darville T. Reduced Endometrial Ascension and Enhanced Reinfection Associated with IgG Antibodies to Specific Chlamydia trachomatis Proteins in Women at Risk for Chlamydia. J Infect Dis. 2021.

MacBrayne CE, Rutstein RM, Wiznia AA, Graham B, Alvero CG, Fairlie L, Lypen K, George KH, Townley E, Moye J, Jr., Costello DG, Reding CA, Barroso Hofer C, Crauwels HM, Woot de Trixhe X, Tambuyzer L, Vanveggel S, Opsomer M, Kiser JJ and the IMPAACT P1090 Protocol Team. Etravirine in treatment-experienced HIV-1-infected children 1 year to less than 6 years of age. AIDS. 35(9):1413-1421. 2021. PMC8270511.

Maia CMA, Pasetto S, Raimundo ESJP, Tavares JF, Costa E and Murata RM. Anandenanthera colubrina (Vell.) Brenan as an inhibitor of HIV-1 BaL infection. Nat Prod Res.1-5. 2021.

Marzinke MA, Grinsztejn B, Fogel JM, Piwowar-Manning E, Li M, Weng L, McCauley M, Cummings V, Ahmed S, Haines CD, Bushman LR, Petropoulos C, Persaud D, Adeyeye A, Kofron R, Rinehart A, St Clair M, Rooney JF, Pryluka D, Coelho L, Gaur A, Middelkoop K, Phanuphak N, Cohen MS, Hendrix CW, Anderson P, Hanscom B, Donnell D, Landovitz RJ and Eshleman SH. Characterization of Human Immunodeficiency Virus (HIV) Infection in Cisgender Men and Transgender Women Who Have Sex With Men Receiving Injectable Cabotegravir for HIV Prevention: HPTN 083. J Infect Dis. 224(9):1581-1592. 2021. PMC8599849.

Masters MC, Perez J, Wu K, Ellis RJ, Goodkin K, Koletar SL, Andrade A, Yang J, Brown TT, Palella FJ, Sacktor N, Tassiopoulos K and Erlandson KM. Baseline Neurocognitive Impairment (NCI) Is Associated With Incident Frailty but Baseline Frailty Does Not Predict Incident NCI in Older Persons With Human Immunodeficiency Virus (HIV). Clin Infect Dis. 73(4):680-688. 2021. PMC8499706.

Meanley S, Choi SK, Thompson AB, Meyers JL, D’Souza G, Adimora AA, Mimiaga MJ, Kempf MC, Konkle-Parker D, Cohen MH, Teplin LA, Murchison L, Rubin LH, Rubtsova AA, Weiss DJ, Aouizerat B, Friedman MR, Plankey MW and Wilson TE. Short-term binge drinking, marijuana, and recreational drug use trajectories in a prospective cohort of people living with HIV at the start of COVID-19 mitigation efforts in the United States. Drug Alcohol Depend. 231:109233. 2022. PMC8709730.

Mollan KR, Eron JJ, Krajewski TJ, Painter W, Duke ER, Morse CG, Goecker EA, Premkumar L, Wolfe CR, Szewczyk LJ, Alabanza PL, Loftis AJ, Degli-Angeli EJ, Brown AJ, Dragavon JA, Won JJ, Keys J, Hudgens MG, Fang L, Wohl DA, Cohen MS, Baric RS, Coombs RW, Sheahan TP and Fischer WA. Infectious Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Virus in Symptomatic Coronavirus Disease 2019 (COVID-19) Outpatients: Host, Disease, and Viral Correlates. Clin Infect Dis. 2021.

Momper JD, Wang J, Stek A, Shapiro DE, Powis KM, Paul ME, Badell ML, Browning R, Chakhtoura N, Denson K, Rungruengthanakit K, George K, Capparelli EV, Mirochnick M, Best BM and IMPAACT P1026s Protocol Team. Pharmacokinetics of Atazanavir Boosted With Cobicistat in Pregnant and Postpartum Women With HIV. J Acquir Immune Defic Syndr. 89(3):303-309. 2022. PMC8837686.

Mulligan N, Salama E, Momper JD, Capparelli EV, Stek A, Chakhtoura N, Mirochnick M, Best BM and IMPAACT P1026s Protocol Team. Lopinavir and tenofovir interaction observed in non-pregnant adults altered during pregnancy. J Clin Pharm Ther. 46(5):1459-1464. 2021. PMC8448937.

Nguyen NC, Luong TN, Le VT, Hobbs M, Andridge R, Casterline J and Gallo MF. Effectiveness of erectogenic condom against semen exposure among women in Vietnam: Randomized controlled trial. PLoS One. 17(2):e0263503. 2022. PMC8853499.

Painschab MS, Kohler R, Kimani S, Mhango W, Kaimila B, Zuze T, Mithi V, Kasonkanji E, Mumba N, Nyasosela R, Wheeler S and Gopal S. Comparison of best supportive care, CHOP, or R-CHOP for treatment of diffuse large B-cell lymphoma in Malawi: a cost-effectiveness analysis. Lancet Glob Health. 9(9):e1305-e1313. 2021. PMC8403678.

Philbin MM, Parish C, Kinnard EN, Reed SE, Kerrigan D, Alcaide ML, Cohen MH, Sosanya O, Sheth AN, Adimora AA, Cocohoba J, Goparaju L, Golub ET, Fischl M and Metsch LR. Interest in Long-Acting Injectable Pre-exposure Prophylaxis (LAI PrEP) Among Women in the Women’s Interagency HIV Study (WIHS): A Qualitative Study Across Six Cities in the United States. AIDS Behav. 25(3):667-678. 2021. PMC7886938.

Piscitelli J, Nikanjam M, Best BM, Acosta E, Mirochnick M, Clarke DF, Capparelli EV and Momper JD. Optimizing Dolutegravir Initiation in Neonates Using Population Pharmacokinetic Modeling and Simulation. J Acquir Immune Defic Syndr. 89(1):108-114. 2022. PMC8665018.

Presti RM, Yeh E, Williams B, Landay A, Jacobson JM, Wilson C, Fichtenbaum CJ, Utay NS, Dube MP, Klingman KL, Estes JD, Flynn JK, Loftin A, Brenchley JM, Andrade A, Kitch DW and Overton ET. A Randomized, Placebo-Controlled Trial Assessing the Effect of VISBIOME ES Probiotic in People With HIV on Antiretroviral Therapy. Open Forum Infect Dis. 8(12):ofab550. 2021. PMC8651169.

Rittenhouse KJ, Mwape H, Nelson JAE, Mwale J, Chipili G, Price JT, Hudgens M, Stringer EM, De Paris K, Vwalika B and Stringer JSA. Maternal HIV, antiretroviral timing, and spontaneous preterm birth in an urban Zambian cohort: the role of local and systemic inflammation. AIDS. 35(4):555-565. 2021. PMC7944942.

Scully EP, Aga E, Tsibris A, Archin N, Starr K, Ma Q, Morse GD, Squires KE, Howell BJ, Wu G, Hosey L, Sieg S, Ehui L, Giguel F, Coxen K, Dobrowlski C, Gandhi M, Deeks S, Chomont N, Connick E, Godfrey C, Karn J, Kuritzkes DR, Bosch RJ, Gandhi RT and A5366 study team. Impact of Tamoxifen on Vorinostat-Induced HIV Expression in Women on Antiretroviral Therapy (ACTG A5366:The MOXIE trial). Clin Infect Dis. 2022.

Sellers SA, Edmonds A, Ramirez C, Cribbs SK, Ofotokun I, Huang L, Morris A, McCormack MC, Kunisaki KM, D’Souza G, Rivera MP, Drummond MB and Adimora AA. Optimal lung cancer screening criteria among persons living with HIV. J Acquir Immune Defic Syndr. 2022.

Sheth AN, Adimora AA, Golub ET, Kassaye SG, Rana A, Westreich D, Cyriaque JW, Parish C, Konkle-Parker D, Jones DL, Kempf MC, Ofotokun I, Kanthula RM, Donohue J, Raccamarich P, Tisdale T, Ramirez C, Warren-Jeanpiere L, Tien PC and Alcaide ML. Study of Treatment and Reproductive Outcomes Among Reproductive-Age Women With HIV Infection in the Southern United States: Protocol for a Longitudinal Cohort Study. JMIR Res Protoc. 10(12):e30398. 2021. PMC8726043.

Solomon SS, Wagner-Cardoso S, Smeaton L, Sowah LA, Wimbish C, Robbins G, Brates I, Scello C, Son A, Avihingsanon A, Linas B, Anthony D, Nunes EP, Kliemann DA, Supparatpinyo K, Kityo C, Tebas P, Bennet JA, Santana-Bagur J, Benson CA, Van Schalkwyk M, Cheinquer N, Naggie S, Wyles D and Sulkowski M. A minimal monitoring approach for the treatment of hepatitis C virus infection (ACTG A5360 [MINMON]): a phase 4, open-label, single-arm trial. Lancet Gastroenterol Hepatol. 2022.

Sugarman J, Donnell DJ, Hanscom B, McCauley M, Grinsztejn B and Landovitz RJ. Ethical issues in establishing the efficacy and safety of long-acting injectable pre-exposure prophylaxis for HIV prevention: the HPTN 083 trial. Lancet HIV. 8(11):e723-e728. 2021.

Takuva S, Karuna ST, Juraska M, Rudnicki E, Edupuganti S, Anderson M, De La Grecca R, Gaudinski MR, Sehurutshi A, Orrell C, Naidoo L, Valencia J, Villela LM, Walsh SR, Andrew P, Karg C, Randhawa A, Hural J, Gomez Lorenzo MM, Burns DN, Ledgerwood J, Mascola JR, Cohen M, Corey L, Mngadi K, Mgodi NM, and the HVTN 703/HPTN 081 and HVTN 704/HPTN 085 Study Teams. Infusion reactions after receiving the broadly neutralizing antibody VRC01 or placebo to reduce HIV-1 acquisition: Results from the phase 2b Antibody Mediated Prevention (AMP) randomized trials. J Acquir Immune Defic Syndr. 2021.

Tsai K, Bogerd HP, Kennedy EM, Emery A, Swanstrom R and Cullen BR. Epitranscriptomic addition of m(6)A regulates HIV-1 RNA stability and alternative splicing. Genes Dev. 35(13-14):992-1004. 2021. PMC8247604.

Vavro C, Ruel T, Wiznia A, Montanez N, Nangle K, Horton J, Buchanan AM, Stewart EL and Palumbo P. Emergence of Resistance in HIV-1 Integrase with Dolutegravir Treatment in a Pediatric Population from the IMPAACT P1093 Study. Antimicrob Agents Chemother. 66(1):e0164521. 2022. PMC8765298.

Waltmann A, Duncan J, Pier G, Cywes-Bentley C, Cohen M and Hobbs M. Experimental urethral infection with Neisseria gonorrhoeae. In: Bagnoli F, Del Giudice G, Phogat S and Rappuoli R, eds. Human Challenge Studies for Vaccine Development. Vol In press. New York, NY: Springer Nature; 2022.

Webster CM, Kasaro MP, Price JT, Stringer EM, Wiesen CA, Vwalika B and Stringer JSA. Seroreduction of syphilis non-treponemal titers during pregnancy for women with and without HIV co-infection. Int J Gynaecol Obstet. 2022.

Willis SK, Aiello AE, Chatterjea D, Nelson JA, Hibberd PL and Harlow BL. Characterizing Differences in Thymic Function in Women With and Without Vulvodynia: A Community-Based Study. J Low Genit Tract Dis. 25(4):296-302. 2021.

Wyles DL, Kang M, Matining RM, Murphy RL and Peters MG. Continued Low Rates of Hepatitis C Virus (HCV) Recurrence in HCV/HIV- and HCV-Infected Participants Who Achieved Sustained Virologic Response After Direct-Acting Antiviral Treatment: Final Results From the AIDS Clinical Trials Group A5320 Viral Hepatitis C Infection Long-term Cohort Study (V-HICS). Open Forum Infect Dis. 8(12):ofab511. 2021. PMC8677564.

Xu Y, Weideman AM, Abad-Fernandez M, Mollan KR, Kallon S, Samir S, Warren JA, Clutton G, Roan N, Adimora AA, Archin N, Kuruc J, Gay C, Hudgens MG and Goonetilleke N. Reliable Estimation of CD8 T Cell Inhibition of In Vitro HIV-1 Replication. Front Immunol. 12:666991. 2021. PMC8278574.

Zhao S, Gockenbach M, Grimstein M, Sachs HC, Mirochnick M, Struble K, Belew Y, Wang J, Capparelli EV, Best BM, Johnson T, Momper JD and Maharaj AR. Characterization of Plasma Protein Alterations in Pregnant and Postpartum Individuals Living With HIV to Support Physiologically-Based Pharmacokinetic Model Development. Front Pediatr. 9:721059. 2021. PMC8550258.

Zhou S, Sizemore S, Moeser M, Zimmerman S, Samoff E, Mobley V, Frost S, Cressman A, Clark M, Skelly T, Kelkar H, Veluvolu U, Jones C, Eron J, Cohen M, Nelson JAE, Swanstrom R and Dennis AM. Near Real-Time Identification of Recent Human Immunodeficiency Virus Transmissions, Transmitted Drug Resistance Mutations, and Transmission Networks by Multiplexed Primer ID-Next-Generation Sequencing in North Carolina. J Infect Dis. 223(5):876-884. 2021. PMC7938176.

Campbell EM, Patala A, Shankar A, Li JF, Johnson JA, Westheimer E, Gay CL, Cohen SE, Switzer WM and Peters PJ. Phylodynamic Analysis Complements Partner Services by Identifying Acute and Unreported HIV Transmission. Viruses. 12(2):145. 2020. PMC7077189.

Curtis AD, Dennis M, Eudailey J, Walter KL, Cronin K, Alam SM, Choudhary N, Tuck RH, Hudgens M, Kozlowski PA, Pollara J, Ferrari G, Van Rompay KKA, Permar S and De Paris K. HIV Env-Specific IgG Antibodies Induced by Vaccination of Neonatal Rhesus Macaques Persist and Can Be Augmented by a Late Booster Immunization in Infancy. mSphere. 5(2):e00162-00120. 2020. PMC7096624.

Dube K, Hosey L, Starr K, Barr L, Evans D, Hoffman E, Campbell D, Simoni J, Sugarman J, Sauceda J, Brown B, Diepstra KL, Godfrey C, Kuritzkes DR, Wohl DA, Gandhi R and Scully E. Participant Perspectives in an HIV Cure-Related Trial Conducted Exclusively in Women in the United States: Results from AIDS Clinical Trials Group (ACTG) 5366. AIDS Res. Hum. Retroviruses. 36(4):268-282. 2020. PMC7185351

Dumond JB, Bay CP, Nelson JAE, Davalos A, Edmonds A, De Paris K, Sykes C, Anastos K, Sharma R, Kassaye S, Tamraz B, French AL, Gange S, Ofotokun I, Fischl MA, Vance DE and Adimora AA. Intracellular Tenofovir and Emtricitabine Concentrations in Younger and Older Women with HIV Receiving Tenofovir Disoproxil Fumarate/Emtricitabine. Antimicrob. Agents Chemother. [Epub ahead of print]. 2020.

Fedoriw Y, Selitsky S, Montgomery ND, Kendall SM, Richards KL, Du W, Tomoka T, Mulenga M, Parker JS, Dave SS and Gopal S. Identifying transcriptional profiles and evaluating prognostic biomarkers of HIV-associated diffuse large B-cell lymphoma from Malawi. Mod. Pathol. [Epub before print]. 2020.

Gay CL, Kuruc JD, Falcinelli SD, Warren JA, Reifeis SA, Kirchherr JL, James KS, Dewey MG, Helms A, Allard B, Stuelke E, Gamble A, Plachco A, Gorelick RJ, Eron JJ, Hudgens M, Garrido C, Goonetilleke N, DeBenedette MA, Tcherepanova IY, Nicolette CA, Archin NM and Margolis DM. Assessing the impact of AGS-004, a dendritic cell-based immunotherapy, and vorinostat on persistent HIV-1 Infection. Sci. Rep. 10(1):5134. 2020. PMC7083965.

Montgomery ND, Randall C, Painschab M, Seguin R, Kaimila B, Kasonkanji E, Zuze T, Krysiak R, Sanders MK, Elliott A, Miller MB, Kampani C, Chimzimu F, Mulenga M, Damania B, Tomoka T, Fedoriw Y, Dittmer DP and Gopal S. High pretreatment plasma Epstein‐Barr virus (EBV) DNA level is a poor prognostic marker in HIV‐associated, EBV‐negative diffuse large B‐cell lymphoma in Malawi. Cancer Med. 9(2):552-561. 2020. PMC6970037.

Muss HB, Smitherman A, Wood WA, Nyrop K, Tuchman S, Randhawa PK, Entwislte A, R., Mitin N and Shachar SS. P16 A Biomarker of Aging and Tolerance for Cancer Therapy. Transl Cancer Res.[Epub before print]. 2020.

Nelson JAE, De Paris K, Ramirez C, Edmonds A, Mollan KR, Bay CP, Compliment K, Herold BC, Anastos K, Minkoff H, Kassaye S, Seidman DL, French AL, Golub ET, Sheth AN, Ochsenbauer C, Swanstrom R, Eron JJ and Adimora AA. Female genital tract shedding of HIV-1 is rare in women with suppressed HIV-1 in plasma. AIDS. 34(1):39-46. 2020. PMC6910230.

Nixon CC, Mavigner M, Sampey GC, Brooks AD, Spagnuolo RA, Irlbeck DM, Mattingly C, Ho PT, Schoof N, Cammon CG, Tharp GK, Kanke M, Wang Z, Cleary RA, Upadhyay AA, De C, Wills SR, Falcinelli SD, Galardi C, Walum H, Schramm NJ, Deutsch J, Lifson JD, Fennessey CM, Keele BF, Jean S, Maguire S, Liao B, Browne EP, Ferris RG, Brehm JH, Favre D, Vanderford TH, Bosinger SE, Jones CD, Routy JP, Archin NM, Margolis DM, Wahl A, Dunham RM, Silvestri G, Chahroudi A and Garcia JV. Systemic HIV and SIV latency reversal via non-canonical NF-kappaB signalling in vivo. Nature. 578(7793):160-165. 2020. PMC7111210.

Orkin C, Eron JJ, Rockstroh J, Podzamczer D, Esser S, Vandekerckhove L, Van Landuyt E, Lathouwers E, Hufkens V, Jezorwski J, Opsomer M and AMBER study group. Week 96 results of a phase 3 trial of darunavir/cobicistat/emtricitabine/tenofovir alafenamide in treatment-naive HIV-1 patients. AIDS. 34(5):707-718. 2020. PMCID Number: Journal In Process.

Rohner E, Rahangdale L, Sanusi B, Knittel AK, Vaughan L, Chesko K, Faherty B, Tulenko SE, Schmitt JW, Romocki LS, Sivaraman V, Nelson JAE and Smith JS. Test Accuracy of Human Papillomavirus in Urine for Detection of Cervical Intraepithelial Neoplasia. J. Clin. Microbiol. 58(3):e01443-01419. 2020. PMC7041584.

Tolley EE, Zangeneh SZ, Chau G, Eron J, Grinsztejn B, Humphries H, Liu A, Siegel M, Bertha M, Panchia R, Li S, Cottle L, Rinehart A, Margolis D, Jennings A, McCauley M and Landovitz RJ. Acceptability of Long-Acting Injectable Cabotegravir (CAB LA) in HIV-Uninfected Individuals: HPTN 077. AIDS Behav. [Epub before print]. 2020. PMC7423859

Viani RM, Ruel T, Alvero C, Fenton T, Acosta EP, Hazra R, Townley E, Palumbo P, Buchanan AM, Vavro C, Singh R, Graham B, Anthony P, George K, Wiznia A and P1093 Study Team. Long-Term Safety and Efficacy of Dolutegravir in Treatment-Experienced Adolescents With Human Immunodeficiency Virus Infection: Results of the IMPAACT P1093 Study. J. Pediatric Infect. Dis. Soc. 9(2):159-165. 2020. PMC4604048

Zia Y, Davis N, Wiener J, Hobbs MM, Lapple D, Chinula L, Tegha G, Msika A, Tang J and Kourtis AP. Factors associated with vaginal detection of prostate-specific antigen among participants in a clinical trial in Malawi. Sex. Transm. Infect. [Epub ahead of print]. 2020.